Literature DB >> 3307050

Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease.

T Ghayur, T A Seemayer, P A Kongshavn, J G Gartner, W S Lapp.   

Abstract

To investigate the role of natural killer (NK) cells in the induction and pathogenesis of graft-versus-host (GVH) disease, +/beige (+/bg; normal NK cell activity) and beige/beige (bg/bg; deficient NK cell activity) parental C57BL/6 (B6) lymphoid cells were used to induce GVH reactions in either B6 X C3H/Hej +/bg (+/bgF1) or B6 X C3H/HeJF1 bg/bg (bg/bg F1) hybrid mice. When B6 bg/bg parental lymphoid cells (PLC) were injected into bg/bg F1 mice, early splenomegaly, early severe suppression of the plaque-forming cell (PFC) response to sheep red blood cell (SRBC), and only partial suppression of T cell mitogen responses to concanavalin A (Con A) and phytohemagglutin (PHA) were observed on day 12 after GVH induction. In the same GVH combination, slightly augmented NK cytotoxic activity was induced and no GVH-induced moderate-to-severe pathological alterations in the liver and pancreas were observed. When bg/bg PLC were injected into +/bg F1 mice, early splenomegaly and pronounced immunosuppression of the PFC response to SRBC and partial suppression of Con A and PHA responses were observed on day 12 after GVH induction. In this combination (bg/bg----+/bg F1), significant NK cell activity was induced, but no moderate-to-severe histopathological alterations were observed. In contrast, when B6 +/bg PLC were injected into either +/bg F1 or bg/bg F1 hybrids, early splenomegaly, and severe immunosuppression of both the PFC response to SRBC and the T cell mitogen responses to Con A and PHA were observed by day 12--which persisted until day 30 after GVH induction. Furthermore, high NK cell activity was recorded and moderate-to-severe histopathological alterations appeared in both +/bg F1 and bg/bg F1 recipients. These results show that the bg/bg PLC can induce GVH-associated early splenomegaly and immunosuppression of the PFC response to SRBC in both the bg/bg F1 and +/bg F1 hybrids, but that it failed to induce moderate-to-severe histopathological alterations, even though NK cell activity of host origin was activated during GVH reactions. Conversely, when +/bg donor cells were used to induce the GVH reaction, splenomegaly and immunosuppression, as well as moderate-to-severe histopathological lesions were induced. These results suggest that donor NK cells rather than host NK cells play an active role in GVH-associated tissue damage, which in turn contributes to the long-term suppression.

Entities:  

Mesh:

Year:  1987        PMID: 3307050     DOI: 10.1097/00007890-198708000-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  Immunological studies of NK cell-deficient beige mice. II. Analysis of T-lymphocyte functions in beige mice.

Authors:  M E Baca; A M Mowat; D M Parrott
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

2.  Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.

Authors:  Cynthia A Ellison; Masaru Taniguchi; Jacqie M M Fischer; Kent T Hayglass; John G Gartner
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

Review 3.  Acute graft-versus-host disease: a bench-to-bedside update.

Authors:  Shernan G Holtan; Marcelo Pasquini; Daniel J Weisdorf
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

Review 4.  Current thoughts on the pathogenesis of graft versus host disease.

Authors:  A L Appleton; L Sviland
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

5.  Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.

Authors:  Nirali N Shah; Kristin Baird; Cynthia P Delbrook; Thomas A Fleisher; Mark E Kohler; Shakuntala Rampertaap; Kimberly Lemberg; Carolyn K Hurley; David E Kleiner; Melinda S Merchant; Stefania Pittaluga; Marianna Sabatino; David F Stroncek; Alan S Wayne; Hua Zhang; Terry J Fry; Crystal L Mackall
Journal:  Blood       Date:  2014-12-01       Impact factor: 22.113

6.  Immunological studies of NK cell-deficient beige mice. I. Defective ability of beige lymphocytes to mediate local and systemic graft-versus-host reactions.

Authors:  M E Baca; A M Mowat
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

7.  Increased expression of proopiomelanocortin (POMC) mRNA in adrenal glands of mice undergoing graft-versus-host disease (GVHD): association with persistent elevated plasma corticosterone levels.

Authors:  K E You-Ten; A Itié; T A Seemayer; R G Palfree; W S Lapp
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

8.  In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.

Authors:  M Sykes; M L Romick; K A Hoyles; D H Sachs
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

9.  Effect of recombinant human keratinocyte growth factor (rHuKGF) on the immunopathogenesis of intestinal graft-vs.-host disease induced without a preconditioning regimen.

Authors:  Cynthia A Ellison; Shannon A Natuik; Jacqie M M Fischer; Alan R McIntosh; Sheila A Scully; Eric J Bow; Dimitry M Danilenko; Kent T Hayglass; John G Gartner
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.317

Review 10.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.